Admetsys Blood Diagnostic System Made Breakthrough Device
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
NSF Health Sciences Certification, LLC, a wholly owned subsidiary of NSF International, was recently authorized as an official Auditing Organization by the Medical Device Single Audit Program (MDSAP) Regulatory Authority Council. MDSAP is a global auditing and monitoring program to improve safety and oversight in the manufacturing of various medical devices.
Emphasizing cleanliness and organization, Lean tools can empower biomeds to design best practices that eliminate waste and improve workflow
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The European Parliament adopted more than 100 amendments to medical device directives that should pave the way for improved device regulation in the European Union.
Read More